ATE58294T1 - Pharmazeutische zusammensetzungen. - Google Patents

Pharmazeutische zusammensetzungen.

Info

Publication number
ATE58294T1
ATE58294T1 AT87306297T AT87306297T ATE58294T1 AT E58294 T1 ATE58294 T1 AT E58294T1 AT 87306297 T AT87306297 T AT 87306297T AT 87306297 T AT87306297 T AT 87306297T AT E58294 T1 ATE58294 T1 AT E58294T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
aqueous solution
taurultam
taurolidine
particularly suitable
Prior art date
Application number
AT87306297T
Other languages
English (en)
Inventor
Rolf Wilhelm Pfirrmann
Original Assignee
Geistlich Soehne Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geistlich Soehne Ag filed Critical Geistlich Soehne Ag
Application granted granted Critical
Publication of ATE58294T1 publication Critical patent/ATE58294T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87306297T 1986-07-17 1987-07-16 Pharmazeutische zusammensetzungen. ATE58294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868617482A GB8617482D0 (en) 1986-07-17 1986-07-17 Pharmaceutical composition
EP87306297A EP0253662B1 (de) 1986-07-17 1987-07-16 Pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE58294T1 true ATE58294T1 (de) 1990-11-15

Family

ID=10601226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87306297T ATE58294T1 (de) 1986-07-17 1987-07-16 Pharmazeutische zusammensetzungen.

Country Status (9)

Country Link
EP (1) EP0253662B1 (de)
JP (1) JP2550356B2 (de)
KR (1) KR950009096B1 (de)
AT (1) ATE58294T1 (de)
AU (1) AU604031B2 (de)
CA (1) CA1287300C (de)
DE (1) DE3766175D1 (de)
ES (1) ES2026184T3 (de)
GB (1) GB8617482D0 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614170B2 (en) * 1988-08-26 1991-08-22 Minnesota Mining And Manufacturing Company A steam sensitive composition and a sterilization indicator composition containing the same
US20030027818A1 (en) 2001-04-03 2003-02-06 Redmond H. Paul Treatment of cancers
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US6479481B1 (en) 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
ATE555780T1 (de) * 1997-10-24 2012-05-15 John P Blass Nahrungsergänzungsmittel für metabolische hirnleistungsstörungen
FR2771928B1 (fr) * 1997-12-05 2001-04-13 Jean Noel Thorel Composition comprenant des derives de taurine ; son utilisation comme agent conservateur d'un produit alimentaire, ou pharmaceutique, topique ou cosmetique
US6117868A (en) * 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US6821968B2 (en) * 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
ES2531547T3 (es) 1999-12-06 2015-03-17 Geistlich Pharma Ag Uso de taurolidina o el taurultamo para la fabricación de un medicamento para el tratamiento de tumores
CN100519525C (zh) 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP5280603B2 (ja) 2001-10-01 2013-09-04 ガイストリッヒ ファーマ アーゲー 転移阻害のための方法
DE07825069T1 (de) 2006-09-07 2010-04-08 Ed Geistlich Söhne Ag Für Chemische Industrie Verfahren zur behandlung von knochenkrebs
WO2013190355A1 (en) 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents
KR102594322B1 (ko) 2014-12-19 2023-10-26 가이스틀리히 파마 아게 옥사티아진-유사 화합물의 제조방법
JP6933659B2 (ja) 2016-03-18 2021-09-08 ガイストリッヒ・ファルマ・アーゲーＧｅｉｓｔｌｉｃｈ Ｐｈａｒｍａ Ａｇ トリプルネガティブ乳癌の治療方法
CA3216783A1 (en) 2021-04-29 2022-11-03 Thomas Mueller Antimicrobial and anticancer agents
EP4565240A1 (de) 2022-08-05 2025-06-11 Geistlich Pharma AG Kombinationstherapie zur behandlung von krebs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH600878A5 (de) * 1975-04-28 1978-06-30 Gaba Ag
DE2731013C2 (de) * 1977-07-08 1982-07-15 Lentia Gmbh Verfahren zur Herstellung einer wäßrigen Infusionslösung
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use
JPS58116413A (ja) * 1981-12-29 1983-07-11 Nippon Kayaku Co Ltd 静注用総合ビタミン剤
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法

Also Published As

Publication number Publication date
EP0253662B1 (de) 1990-11-14
KR880001283A (ko) 1988-04-22
GB8617482D0 (en) 1986-08-28
CA1287300C (en) 1991-08-06
KR950009096B1 (ko) 1995-08-14
AU7578587A (en) 1988-01-21
DE3766175D1 (de) 1990-12-20
EP0253662A1 (de) 1988-01-20
AU604031B2 (en) 1990-12-06
JP2550356B2 (ja) 1996-11-06
JPS6372626A (ja) 1988-04-02
ES2026184T3 (es) 1992-04-16

Similar Documents

Publication Publication Date Title
ATE58294T1 (de) Pharmazeutische zusammensetzungen.
NO2002009I2 (no) Tiotropium
DE3772924D1 (de) Gegen oxydierung und verfaerbung stabilisierte arzneimittelzubereitungen.
DK543687A (da) Stabiliseret farmaceutisk praeparat
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
FI892498A0 (fi) Aromatiska och heterocykliska karboxiamidderivat saosom antitumoera aemnen.
DK463989D0 (da) Farmaceutisk virksom kombination
ES2093650T3 (es) Una solucion farmaceutica que comprende derivados de fk506.
ES2126636T3 (es) Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
FI851261A0 (fi) Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
CA1271748C (en) BENZAZEPINE DERIVATIVES
ATE104149T1 (de) Dialysier- und spuelloesung zur intraperitonealen verarbreichung.
ES2109244T3 (es) Medicamentos que contienen compuestos de 3,7-diazabiciclo(3,3,1)nonano.
DE68907845D1 (de) Verbrueckte bicyclische 4-(4-(3-benzisothiazolyl)-1-piperazinyl)-butylimide mit antipsychotischer wirkung.
ATE71380T1 (de) Aminoacylderivate von 4,9-dihydro-10h-pyrido(3,2b>thieno(3,2-e>(1,4>diazepinonen und 4,9-dihydro10h-pyrido(3,2-b>thieno(3,4-e>(1,4>diazepinonen ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
DE3852245D1 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel.
DK656389A (da) Phenyl-triazol-pyrimidin-derivat og dets anvendelse som laegemiddel
IT8519182A0 (it) Derivati pirido-benzotiazinici adattivita' antimicrobica.